First-trimester and second-trimester screening at a community hospital: Experience from the first year of implementation

Obstetrics and Gynecology

Volumn 112, Issue 2, 2008, Pages 218-222

  Philipson, Elliot H ^a   Callahan, Michelle ^a   Jelovsek, J Eric ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANEUPLOIDY; ARTICLE; BLOOD ANALYSIS; COMMUNITY HOSPITAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; ETHNICITY; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; GESTATIONAL AGE; HUMAN; INVASIVE PROCEDURE; MATERNAL AGE; MEDICAL RECORD REVIEW; NUCHAL TRANSLUCENCY MEASUREMENT; NULLIPARA; PATIENT REFERRAL; PATIENT SATISFACTION; PRENATAL SCREENING; PRIORITY JOURNAL; RISK; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; METHODOLOGY; PREGNANCY; PROGRAM DEVELOPMENT; UNITED STATES;

ADULT; ANEUPLOIDY; FEMALE; HOSPITALS, COMMUNITY; HUMANS; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; OHIO; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROGRAM DEVELOPMENT; RISK ASSESSMENT;

EID: 51649114091     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31817e7c32     Document Type: Article

References (11)

1. Nicolaides KH, Chervenak FA, McCullough LB, Avgidou K, Papageorghiou A. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol 2005;193:322-6.
2. Palomaki GE, Steinort K, Knight GJ, Haddow JE. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers [published erratum appears in Obstet Gynecol 2006;107:955]. Obstet Gynecol 2006;107:367-75.
3. Simpson JL. Choosing the best prenatal screening protocol. N Engl J Med 2005;353:2068-70.
4. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkens K, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003;349:1405-13.
5. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med 2005;353:2001-11.
6. Perni SC, Predanic M, Kalish RB, Chervenak FA, Chasen ST. Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials. Am J Obstet Gynecol 2006;194:127-30.
7. Sharma G, Gold HT, Chervenak FA, McCullough L, Alt AK, Chasen ST. Patient preference regarding first-trimester aneuploidy risk assessment. Am J Obstet Gynecol 2005;193:1429-36.
8. Chasen ST, McCullough LB, Chervenak FA. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population? Am J Obstet Gynecol 2004;190:769-74.
9. Screening for fetal chromosomal abnormalities. ACOG Practice Bulletin No. 77. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;109:217-27.
10. Births in US hospitals by obstetrics level, FY 2006. AHA Annual Survey Database, AHA Resource Center, Chicago (IL), 2007.
11. Reddy UM, Mennuti MT. Incorporating first-trimester Down syndrome studies into prenatal screening: executive summary of the National Institute of Child Health and Human Development workshop. Obstet Gynecol 2006;107:167-73.